Sanofi India Board Meeting to Consider Q2/9M FY26 Results and Interim Dividend
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 19 Oct 2026, 08:03 PM IST · BSE ID: 96c9fbfa-7692-44cc-a09a-d5b714b509df
View Original BSE Filing (PDF)
⚡ Quick Answer
Sanofi India Limited's Board of Directors will meet on October 29, 2026, to consider and approve the Unaudited Financial Results for the quarter and nine-months ended September 30, 2026. They may also declare an interim dividend for the financial year 2026. The trading window for Sanofi India shares closed on October 1, 2026.
💡
In Simple Terms
Sanofi India's board will meet on October 29, 2026, to review financial results and may announce a dividend.
🤖 AI Summary
- Sanofi India's Board will convene on Thursday, October 29, 2026, to review financial results.
- The board meeting agenda includes considering and approving Unaudited Financial Results for Q2 and 9M FY26.
- Consideration, declaration, and approval of an Interim dividend for financial year 2026 is also on the agenda.
- Trading window for company shares remains closed from October 1, 2026, until 48 hours post-results.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders should await the outcome of the board meeting on October 29, 2026.
👤
Who Is Affected
All shareholders of Sanofi India Limited will be affected by any potential interim dividend declaration and by the upcoming financial performance announcement.
🔍
Management Signal
The decision to consider an interim dividend signals management's ongoing commitment to shareholder returns, subject to financial performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Sanofi India's Q2 and 9M FY26 unaudited financial results announcement on October 29, 2026.
Interim dividend declaration details for FY2026, if approved.
Trading window reopening post-results, expected around November 1, 2026.
LOW RISK
This filing is a routine board meeting intimation, carrying minimal inherent risk.
💡 Investor Takeaway
Sanofi India Limited has scheduled a Board Meeting for October 29, 2026, to approve unaudited financial results for the quarter and nine-months ended September 30, 2026. The board will also consider declaring an Interim dividend for FY2026.
📅 Company Track Record
Sanofi India's past filings include an investor call for Q1/H1 FY27 results on August 5, 2026. The company reported Q4 FY26 unaudited financial results with its insulin portfolio growing 19% YoY to ₹4,723 Million revenue, despite an 11.6% total revenue decline due to partnership transitions.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When is Sanofi India Limited's next Board Meeting scheduled?
Sanofi India Limited's Board of Directors meeting is scheduled for Thursday, October 29, 2026.
What is the agenda for Sanofi India Limited's upcoming Board Meeting on October 29, 2026?
The agenda includes considering and approving the Unaudited Financial Results for the quarter and nine-months ended September 30, 2026, and potentially declaring an Interim dividend for FY26.
When did the trading window for Sanofi India shares close?
The trading window for Sanofi India shares closed on October 1, 2026.
When will the trading window for Sanofi India shares reopen?
The trading window for Sanofi India shares will reopen 48 hours after the results announcement.
Questions based on this BSE filing only. For information purposes.